 tamoxifen premenopaus patient metastat breast cancer review antiestrogen tamoxifen hormon therapi breast cancer drug antiprolif effect estrogen receptor ER mechan cellular action tumor inhibit clinic tamoxifen premenopaus postmenopaus patient drug complex endocrin effect depend treatment durat dose menopaus statu target organ postmenopaus women tamoxifen serum estrogen level low gonadotropin level decreas contrast estrogen level mani premenopaus women gonadotropin concentr unchang larg systemat trial metastat breast cancer tamoxifen recommend hormon therapi postmenopaus women er-posit tumor tamoxifen activ agent premenopaus metastat diseas respons rate compar oophorectomi clinic experi tamoxifen age group limit few premenopaus women phase II phase iii trial random trial total patient oophorectomi tamoxifen therapeut equival surviv advantag treatment mani question appropri role tamoxifen premenopaus patient attract toxic profil favor therapeut altern premenopaus women er-posit metastat breast cancer surgic radiat castrat